Oxylan 40mg prolonged-release tablets (G.L. Pharma UK Ltd)
BNF presentation 0407020ADBFADAH within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0407020ADBFADAH
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
122
NHS spend (£)
£2,722.96
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 35 |
| December 2024 | 8 |
| November 2024 | 27 |
| October 2024 | 14 |
| August 2024 | 2 |
| July 2024 | 27 |
| May 2024 | 3 |
| July 2021 | 2 |
| June 2021 | 1 |
| December 2020 | 2 |
| November 2020 | 1 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 10 | No data available |
| Unknown pharmacy | 8 | No data available |
| Unknown pharmacy | 7 | No data available |
| Unknown pharmacy | 5 | No data available |
| Unknown pharmacy | 5 | No data available |
| Unknown pharmacy | 5 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |